Influenza Medication Market Size, Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

  • TBI906036
  • August 19, 2020
  • Global
  • 132 pages
  • ROIF Expert
                                          

We have updated Influenza Medication Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Influenza Medication market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Influenza Medication market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Influenza Medication Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Influenza Medication Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Influenza Medication Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.

List of Companies Profiled

Market Players like Genentech, Inc., Shionogi & Co., Ltd., and GlaxoSmithKline plc to Strengthen the Market Position The influenza medication market analysis shows that this market is dominated by some key companies owing to their strong product portfolio, key strategic decisions, and dominance of market share. These include a group of 2-3 key companies with wider geographic presence and continued R&D, resulting in strong regulatory approvals. Furthermore, a number of other companies operating in generics are also present in the market. The global market is mature, has a heavy presence of generics, and is difficult in terms of entry for new competitors.

List Of Key Companies Covered:

  • Genentech, Inc.
  • Shionogi & Co., Ltd.
  • Seqirus (CSL)
  • BIOCRYST PHARMACEUTICALS, INC.
  • GlaxoSmithKline plc
  • Lupin Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Pharmaceuticals, Inc. (Zydus Cadila)
  • Amneal Pharmaceuticals LLC
  • Macleods Pharmaceuticals Ltd.
  • Alvogen
  • Others

REPORT COVERAGE

The increasing awareness of influenza, unmet patient needs, and anticipated and new product launches based on advanced technologies is expected to increase the global influenza therapeutics market growth. Along with this, the influenza medication market report provides an extensive analysis of the global market dynamics and competitive landscape and scenario. Various key insights presented in the report are the overview of influenza epidemiology, pipeline analysis, key industry developments, new product launches, analysis of disease burden of influenza, by key regions, regulatory scenario by key countries, and analysis of the impact of the launch of generics on the influenza medication market growth. Along with this other key insights includes key strategies adopted by market leaders, competitive landscape, and company profiles. Report Scope & Segmentation  

Segmentation

By Treatment

  • Baloxavir marboxil
  • Oseltamivir phosphate
  • Others

By Influenza Type

  • Influenza A
  • Influenza B

By Route of Administration

  • Oral
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT:

October 2019

: Genentech, Inc. announced the FDA approval of Xofluza (Baloxavir Marboxil) for individuals at an elevated risk of developing influenza-related complications.

October 2019

: Shionogi & Co., Ltd. announced the filing of a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) in Japan for the postexposure prophylaxis of influenza virus infection.

August 2019

: Shionogi & Co., Ltd. announced the approval of Xofluza (Baloxavir Marboxil) 20mg tablets for the treatment of influenza types A and B in patients over the age of 12 in Taiwan.  

Table of Content
Chapter 1. Methodology and Scope 
1.1. Research Methodology 
1.2. Research Scope & Assumptions 
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Influenza Medication Market
3.1. Market Segmentation 
3.2. Market Size and Growth Prospects, 2019 - 2029 
3.3. Value Chain Analysis 
3.4. Market Dynamics 
3.4.1. Market driver analysis 
3.4.2. Market restraint analysis
Chapter 4. Market Size by Application
4.1 Influenza Medication Market Consumption by Application (2015-2020) 
4.2 Influenza Medication Market Consumption by Application (2020-2029) 

|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form